Overview
HELP market data
Price History
HELP price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$9.41 Diluted earnings per share over the trailing twelve months.
- Beta
- — Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -3,728.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $5.30 – $16.30 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.9M · P/B 1.50.
Company News
Helus Pharma Q1 EPS $(0.91) Beats $(1.07) EstimateBenzinga · Aug 14, 2026, 11:53 AM
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · Aug 10, 2026, 12:02 PM
Helus Pharma Appoints Michael Halstead CEO, Effective ImmediatelyBenzinga · Aug 3, 2026, 11:44 AM
Wells Fargo Initiates Coverage On Helus Pharma with Overweight Rating, Announces Price Target of $16Benzinga · Jul 27, 2026, 12:52 PM
Crude Oil Surges 2%; 3M Shares Gain After Q2 ResultsBenzinga · Jul 21, 2026, 6:18 PM
Hasbro, Utz Brands, Park Aerospace And Other Big Stocks Moving Higher On TuesdayBenzinga · Jul 21, 2026, 2:37 PM
Helus Pharma shares are trading higher after the company announced it completed enrollment in its APPROACH Phase 3 pivotal study of HLP003 in patients living with Major Depressive Disorder.Benzinga · Jul 21, 2026, 1:58 PM
Helus Pharma Completes Enrollment In Its APPROACH Phase 3 Study Of HLP003 In Patients Living With Major Depressive Disorder; Topline Data Readout On Track For Q4 2026Benzinga · Jul 21, 2026, 11:52 AM
Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On ThursdayBenzinga · Jul 16, 2026, 2:11 PM
Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 16, 2026, 8:26 AM